Results 91 to 100 of about 38,436 (213)
Diabetes Secondary to Acromegaly: Physiopathology, Clinical Features and Effects of Treatment
Frontiers in Endocrinology, 2018 Acromegaly is a rare disease due to chronic GH excess and to the consequent increase in IGF-1 levels. Both GH and IGF-1 play a role in intermediate metabolism affecting glucose homeostasis. Indeed, chronic GH excess impairs insulin sensitivity, increases
F. Ferraù +4 more
semanticscholar +1 more source
Journal of Neuroendocrinology, Volume 37, Issue 3, March 2025.Abstract Peptide receptor radionuclide therapy (PRRT) is an effective treatment for both oncological and hormone control and is a widely accepted standard of care treatment for patients with neuroendocrine neoplasms (NEN). Its use is anticipated to increase significantly, and this demands accurate tools and paradigms to assess treatment response post ...
Grace Kong +5 more
wiley +1 more source
Endokrynologia Polska, 2019 Acromegaly is a rare disease caused by excessive production of growth hormone (GH), typically by a pituitary tumour. The diagnosis is usually delayed, and patients frequently develop various complications that cause premature mortality.
M. Bolanowski +5 more
semanticscholar +1 more source
European Journal of Endocrinology, 2019 Growth hormone (GH) and insulin-like growth factor-I (IGF-I) exert physiological actions on the skeleton throughout life, by stimulating longitudinal bone growth in children, the acquisition of bone mass during adolescence and the maintenance of skeletal
G. Mazziotti, A. Lania, E. Canalis
semanticscholar +1 more source
Upper and lower gastrointestinal tract disorders in patients with newly diagnosed acromegaly
Alʹmanah Kliničeskoj Mediciny, 2016 Background: Increased growth hormone production in acromegaly results in enlargement of inner organs, their dysfunction and morphological abnormalities.
A. A. Titaeva +3 more
doaj +1 more source
European Journal of Endocrinology, 2017 CONTEXT Acromegaly is a rare disease associated with chronic multisystem complications. National registries have been created in several countries.
L. Maione +10 more
semanticscholar +1 more source
E‐cadherin expression is associated with somatostatin analogue response in acromegaly
Journal of Cellular and Molecular Medicine, 2019 Acromegaly is a rare disease resulting from hypersecretion of growth hormone (GH) and insulin‐like growth factor 1 (IGF1) typically caused by pituitary adenomas, which is associated with increased mortality and morbidity.
Eva Venegas-Moreno +10 more
semanticscholar +1 more source
Diagnosis and Treatment of Acromegaly: An Update.
Mayo Clinic proceedings, 2022 Nazanin Ershadinia, N. Tritos
semanticscholar +1 more source
Non-invasive DXA-derived bone structure assessment of acromegaly patients: a cross-sectional study.
European Journal of Endocrinology, 2019 Introduction Impaired bone microarchitecture is involved in vertebral fracture (VF) development among acromegaly patients. Aim of the study Comparison of DXA-derived bone parameters, areal BMD (aBMD), trabecular bone score (TBS) and 3D-SHAPER parameters ...
M. Kuzma +9 more
semanticscholar +1 more source
A case of acromegaly complicated with diabetic ketoacidosis, pituitary apoplexy, and lymphoma
Kaohsiung Journal of Medical Sciences, 2013 Acromegaly is always complicated with comorbidities and increased mortality. The disease activity and mortality outcomes are highly correlated to the level of growth hormone and insulin-like growth factor 1.
He-Jiun Jiang +2 more
doaj +1 more source